Cargando…
Aspidosperma pyrifolium, a medicinal plant from the Brazilian caatinga, displays a high antiplasmodial activity and low cytotoxicity
BACKGROUND: Several species of Aspidosperma plants are referred to as remedies for the treatment of malaria, especially Aspidosperma nitidum. Aspidosperma pyrifolium, also a medicinal plant, is used as a natural anti-inflammatory. Its fractionated extracts were assayed in vitro for activity against...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257952/ https://www.ncbi.nlm.nih.gov/pubmed/30477525 http://dx.doi.org/10.1186/s12936-018-2568-y |
_version_ | 1783374428779839488 |
---|---|
author | Ceravolo, Isabela P. Zani, Carlos L. Figueiredo, Flávio J. B. Kohlhoff, Markus Santana, Antônio E. G. Krettli, Antoniana U. |
author_facet | Ceravolo, Isabela P. Zani, Carlos L. Figueiredo, Flávio J. B. Kohlhoff, Markus Santana, Antônio E. G. Krettli, Antoniana U. |
author_sort | Ceravolo, Isabela P. |
collection | PubMed |
description | BACKGROUND: Several species of Aspidosperma plants are referred to as remedies for the treatment of malaria, especially Aspidosperma nitidum. Aspidosperma pyrifolium, also a medicinal plant, is used as a natural anti-inflammatory. Its fractionated extracts were assayed in vitro for activity against malaria parasites and for cytotoxicity. METHODS: Aspidosperma pyrifolium activity was evaluated against Plasmodium falciparum using extracts in vitro. Toxicity towards human hepatoma cells, monkey kidney cells or human monocytes freshly isolated from peripheral blood was also assessed. Anti-malarial activity of selected extracts and fractions that presented in vitro activity were tested in mice with a Plasmodium berghei blood-induced infection. RESULTS: The crude stem bark extract and the alkaloid-rich and ethyl acetate fractions from stem extract showed in vitro activity. None of the crude extracts or fractions was cytotoxic to normal monkey kidney and to a human hepatoma cell lines, or human peripheral blood mononuclear cells; the MDL(50) values of all the crude bark extracts and fractions were similar or better when tested on normal cells, with the exception of organic and alkaloidic-rich fractions from stem extract. Two extracts and two fractions tested in vivo caused a significant reduction of P. berghei parasitaemia in experimentally infected mice. CONCLUSION: Considering the high therapeutic index of the alkaloidic-rich fraction from stem extract of A. pyrifolium, it makes the species a candidate for further investigation aiming to produce a new anti-malarial, especially considering that the active extract has no toxicity, i.e., no mutagenic effects in the genototoxicity assays, and that it has an in vivo anti-malarial effect. In its UPLC-HRMS analysis this fraction was shown to have two major components compatible with the bisindole alkaloid Leucoridine B, and a novel compound, which is likely to be responsible for the activity against malaria parasites demonstrated in in vitro tests. |
format | Online Article Text |
id | pubmed-6257952 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62579522018-11-29 Aspidosperma pyrifolium, a medicinal plant from the Brazilian caatinga, displays a high antiplasmodial activity and low cytotoxicity Ceravolo, Isabela P. Zani, Carlos L. Figueiredo, Flávio J. B. Kohlhoff, Markus Santana, Antônio E. G. Krettli, Antoniana U. Malar J Research BACKGROUND: Several species of Aspidosperma plants are referred to as remedies for the treatment of malaria, especially Aspidosperma nitidum. Aspidosperma pyrifolium, also a medicinal plant, is used as a natural anti-inflammatory. Its fractionated extracts were assayed in vitro for activity against malaria parasites and for cytotoxicity. METHODS: Aspidosperma pyrifolium activity was evaluated against Plasmodium falciparum using extracts in vitro. Toxicity towards human hepatoma cells, monkey kidney cells or human monocytes freshly isolated from peripheral blood was also assessed. Anti-malarial activity of selected extracts and fractions that presented in vitro activity were tested in mice with a Plasmodium berghei blood-induced infection. RESULTS: The crude stem bark extract and the alkaloid-rich and ethyl acetate fractions from stem extract showed in vitro activity. None of the crude extracts or fractions was cytotoxic to normal monkey kidney and to a human hepatoma cell lines, or human peripheral blood mononuclear cells; the MDL(50) values of all the crude bark extracts and fractions were similar or better when tested on normal cells, with the exception of organic and alkaloidic-rich fractions from stem extract. Two extracts and two fractions tested in vivo caused a significant reduction of P. berghei parasitaemia in experimentally infected mice. CONCLUSION: Considering the high therapeutic index of the alkaloidic-rich fraction from stem extract of A. pyrifolium, it makes the species a candidate for further investigation aiming to produce a new anti-malarial, especially considering that the active extract has no toxicity, i.e., no mutagenic effects in the genototoxicity assays, and that it has an in vivo anti-malarial effect. In its UPLC-HRMS analysis this fraction was shown to have two major components compatible with the bisindole alkaloid Leucoridine B, and a novel compound, which is likely to be responsible for the activity against malaria parasites demonstrated in in vitro tests. BioMed Central 2018-11-26 /pmc/articles/PMC6257952/ /pubmed/30477525 http://dx.doi.org/10.1186/s12936-018-2568-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Ceravolo, Isabela P. Zani, Carlos L. Figueiredo, Flávio J. B. Kohlhoff, Markus Santana, Antônio E. G. Krettli, Antoniana U. Aspidosperma pyrifolium, a medicinal plant from the Brazilian caatinga, displays a high antiplasmodial activity and low cytotoxicity |
title | Aspidosperma pyrifolium, a medicinal plant from the Brazilian caatinga, displays a high antiplasmodial activity and low cytotoxicity |
title_full | Aspidosperma pyrifolium, a medicinal plant from the Brazilian caatinga, displays a high antiplasmodial activity and low cytotoxicity |
title_fullStr | Aspidosperma pyrifolium, a medicinal plant from the Brazilian caatinga, displays a high antiplasmodial activity and low cytotoxicity |
title_full_unstemmed | Aspidosperma pyrifolium, a medicinal plant from the Brazilian caatinga, displays a high antiplasmodial activity and low cytotoxicity |
title_short | Aspidosperma pyrifolium, a medicinal plant from the Brazilian caatinga, displays a high antiplasmodial activity and low cytotoxicity |
title_sort | aspidosperma pyrifolium, a medicinal plant from the brazilian caatinga, displays a high antiplasmodial activity and low cytotoxicity |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257952/ https://www.ncbi.nlm.nih.gov/pubmed/30477525 http://dx.doi.org/10.1186/s12936-018-2568-y |
work_keys_str_mv | AT ceravoloisabelap aspidospermapyrifoliumamedicinalplantfromthebraziliancaatingadisplaysahighantiplasmodialactivityandlowcytotoxicity AT zanicarlosl aspidospermapyrifoliumamedicinalplantfromthebraziliancaatingadisplaysahighantiplasmodialactivityandlowcytotoxicity AT figueiredoflaviojb aspidospermapyrifoliumamedicinalplantfromthebraziliancaatingadisplaysahighantiplasmodialactivityandlowcytotoxicity AT kohlhoffmarkus aspidospermapyrifoliumamedicinalplantfromthebraziliancaatingadisplaysahighantiplasmodialactivityandlowcytotoxicity AT santanaantonioeg aspidospermapyrifoliumamedicinalplantfromthebraziliancaatingadisplaysahighantiplasmodialactivityandlowcytotoxicity AT krettliantonianau aspidospermapyrifoliumamedicinalplantfromthebraziliancaatingadisplaysahighantiplasmodialactivityandlowcytotoxicity |